{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.580","meta":{"versionId":"5","lastUpdated":"2019-03-19T01:00:22.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.580","version":"20190319","name":"Trastuzumab administered within 12 months of diagnosis","status":"active","date":"2019-03-19T01:00:22-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"G9835","display":"Trastuzumab administered within 12 months of diagnosis"}]}]},"expansion":{"identifier":"urn:uuid:aec6f767-e186-4237-af6d-19fb60235e6c","timestamp":"2022-06-10T12:38:31-04:00","total":0,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}]}}